Cosmetics Industry Stakeholders Not Thrilled About Senate Reform Bill, And Why Should They Be?
Executive Summary
In HBW Insight’s conversations with industry advocates about legislation in the US Senate to reform US cosmetics regulations, frustrations with the process have been palpable. Stakeholders suggest that science and proportionality are taking back seats to politics and that concerns about costs to industry, which ultimately could be passed on to consumers, are not being taken seriously enough.
You may also be interested in...
Cosmetics Reform In, Dietary Supplements Out Of US Omnibus Spending Bill
The must-pass federal spending bill includes the Modernization of Cosmetics Regulation Act, which previously appeared as a rider in US Food and Drug Administration user-fee legislation but was cut from the final iteration.
Making Cosmetics Reform Beneficial For All; Former FDA Cosmetics Director Yearns For ‘Serious Sit-Down’
Federal legislative reform is an historic opportunity not only to strengthen the US FDA’s oversight of the cosmetics sector, but also to modernize the industry and its value proposition to consumers. John Bailey, independent advisor for cosmetics and colors at EAS Consulting Group, is confident there’s a way to do all, but "serious" stakeholder negotiations are needed.
Senate HELP Draft For Cosmetics Reform Does Not Go Far Enough – NGOs
A coalition of businesses and advocacy groups including Breast Cancer Prevention Partners, Black Women for Wellness, and Women’s Voices for the Earth believes the Senate HELP Committee’s discussion draft for modernizing US cosmetics regulation should do more to protect communities of color and professional salon workers, and preemption language should be nixed altogether.